Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line

FE Bennani, L Doudach, Y Cherrah, Y Ramli… - Bioorganic …, 2020 - Elsevier
Pyrazole is a five-membered aromatic heterocyclic ring with two adjacent nitrogen atoms C 3
H 3 N 2 H. The presence of this nucleus in pharmacological agents of various therapeutic …

Recent advances in bioactive pyrazoles

ŞG Küçükgüzel, S Şenkardeş - European Journal of Medicinal Chemistry, 2015 - Elsevier
Pyrazole is a five membered and two-nitrogen containing heterocyclic ring. These structures
have been investigated in the development of novel compounds with hypoglycemic …

Cancer and inflammation: an old intuition with rapidly evolving new concepts

G Trinchieri - Annual review of immunology, 2012 - annualreviews.org
Recent scientific advances have contributed much to the dissection of the complex
molecular and cellular pathways involved in the connection between cancer and …

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

MJ Thun, SJ Henley, C Patrono - Journal of the National Cancer …, 2002 - academic.oup.com
Numerous experimental, epidemiologic, and clinical studies suggest that nonsteroidal anti-
inflammatory drugs (NSAIDs), particularly the highly selective cyclooxygenase (COX)-2 …

Aspirin use and survival after diagnosis of colorectal cancer

AT Chan, S Ogino, CS Fuchs - Jama, 2009 - jamanetwork.com
Context Aspirin reduces risk of colorectal neoplasia in randomized trials and inhibits tumor
growth and metastases in animal models. However, the influence of aspirin on survival after …

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

RA Gupta, RN DuBois - Nature Reviews Cancer, 2001 - nature.com
Population-based studies have established that long-term intake of non-steroidal anti-
inflammatory drugs (NSAIDs), compounds that inhibit the enzymatic activity of …

Cyclooxygenase-2: a therapeutic target

ME Turini, RN DuBois - Annual review of medicine, 2002 - annualreviews.org
▪ Abstract Cyclooxygenase (COX), also known as prostaglandin endoperoxide synthase, is
the key enzyme required for the conversion of arachidonic acid to prostaglandins. Two COX …

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

K Subbaramaiah, AJ Dannenberg - Trends in pharmacological sciences, 2003 - cell.com
Abstract Cyclooxygenase2 (COX-2), an inducible prostaglandin G/H synthase, is
overexpressed in several human cancers. Here, the potential utility of selective COX-2 …

COX-2: a molecular target for colorectal cancer prevention

JR Brown, RN DuBois - Journal of Clinical Oncology, 2005 - ascopubs.org
Cyclooxygenase (COX), a key enzyme in the prostanoid biosynthetic pathway, has received
considerable attention due to its role in human cancers. Observational and randomized …

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer

AJ Dannenberg, NK Altorki, JO Boyle, C Dang… - The lancet …, 2001 - thelancet.com
Understanding the mechanisms underlying carcinogenesis provides insights that are
necessary for the development of therapeutic strategies to prevent cancer …